Global Antacid Market Insights and Forecast to 2027

Publisher Name :
Date: 11-Jun-2021
No. of pages: 113
Inquire Before Buying

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid.

The global average price of Antacid is in the decreasing trend, from 11.43 USD/Unit in 2013 to 10.73 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.

Market Analysis and Insights: Global Antacid Market

The global Antacid market is valued at US$ 6225.7 million in 2019. The market size will reach US$ 6587 million by the end of 2026, growing at a CAGR of 0.8% during 2021-2026.

Global Antacid Scope and Market Size

Antacid market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antacid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

- Proton Pump Inhibitor

- H2 Antagonist

- Acid Neutralizers

Segment by Application

- OTC Drug

- Rx Drug

By Company

- AstraZeneca

- Takeda Pharmaceutical

- Pfizer

- Reckitt Benckiser

- Bayer

- Procter?Gamble

- GlaxoSmithKline

- Johnson?Johnson

- CONBA

- Xiuzheng Pharma

- Sanofi

- Bausch Health

- CR SANJIU

- Reddy's Laboratories

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

Global Antacid Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Antacid Product Introduction
1.2 Market by Type
1.2.1 Global Antacid Market Size Growth Rate by Type
1.4.2 Proton Pump Inhibitor
1.4.3 H2 Antagonist
1.2.4 Acid Neutralizers
1.3 Market by Application
1.3.1 Global Antacid Market Size Growth Rate by Application
1.3.2 OTC Drug
1.3.3 Rx Drug
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antacid Sales Estimates and Forecasts 2016-2027
2.2 Global Antacid Revenue Estimates and Forecasts 2016-2027
2.3 Global Antacid Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Antacid Regions by Sales
2.4.1 Global Top Antacid Regions by Sales (2016-2021)
2.4.2 Global Top Antacid Regions by Sales (2022-2027)
2.5 Global Top Antacid Regions by Revenue
2.5.1 Global Top Antacid Regions by Revenue (2016-2021)
2.5.2 Global Top Antacid Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antacid Sales by Manufacturers
3.1.1 Global Top Antacid Manufacturers by Sales (2016-2021)
3.1.2 Global Top Antacid Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Antacid Sales in 2020
3.2 Global Antacid Revenue by Manufacturers
3.2.1 Global Top Antacid Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Antacid Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Antacid Revenue in 2020
3.3 Global Antacid Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antacid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antacid Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antacid Sales by Type
4.1.1 Global Antacid Historical Sales by Type (2016-2021)
4.1.2 Global Antacid Forecasted Sales by Type (2022-2027)
4.1.3 Global Antacid Sales Market Share by Type (2016-2027)
4.2 Global Antacid Revenue by Type
4.2.1 Global Antacid Historical Revenue by Type (2016-2021)
4.2.2 Global Antacid Forecasted Revenue by Type (2022-2027)
4.2.3 Global Antacid Revenue Market Share by Type (2016-2027)
4.3 Global Antacid Price by Type
4.3.1 Global Antacid Price by Type (2016-2021)
4.3.2 Global Antacid Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Antacid Sales by Application
5.1.1 Global Antacid Historical Sales by Application (2016-2021)
5.1.2 Global Antacid Forecasted Sales by Application (2022-2027)
5.1.3 Global Antacid Sales Market Share by Application (2016-2027)
5.2 Global Antacid Revenue by Application
5.2.1 Global Antacid Historical Revenue by Application (2016-2021)
5.2.2 Global Antacid Forecasted Revenue by Application (2022-2027)
5.2.3 Global Antacid Revenue Market Share by Application (2016-2027)
5.3 Global Antacid Price by Application
5.3.1 Global Antacid Price by Application (2016-2021)
5.3.2 Global Antacid Price Forecast by Application (2022-2027)
6 North America
6.1 North America Antacid Market Size by Type
6.1.1 North America Antacid Sales by Type (2016-2027)
6.1.2 North America Antacid Revenue by Type (2016-2027)
6.2 North America Antacid Market Size by Application
6.2.1 North America Antacid Sales by Application (2016-2027)
6.2.2 North America Antacid Revenue by Application (2016-2027)
6.3 North America Antacid Market Size by Country
6.3.1 North America Antacid Sales by Country (2016-2027)
6.3.2 North America Antacid Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antacid Market Size by Type
7.1.1 Europe Antacid Sales by Type (2017-2027)
7.1.2 Europe Antacid Revenue by Type (2017-2027)
7.2 Europe Antacid Market Size by Application
7.2.1 Europe Antacid Sales by Application (2017-2027)
7.2.2 Europe Antacid Revenue by Application (2017-2027)
7.3 Europe Antacid Market Size by Country
7.3.1 Europe Antacid Sales by Country (2017-2027)
7.3.2 Europe Antacid Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antacid Market Size by Type
8.1.1 Asia Pacific Antacid Sales by Type (2018-2027)
8.1.2 Asia Pacific Antacid Revenue by Type (2018-2027)
8.2 Asia Pacific Antacid Market Size by Application
8.2.1 Asia Pacific Antacid Sales by Application (2018-2027)
8.2.2 Asia Pacific Antacid Revenue by Application (2018-2027)
8.3 Asia Pacific Antacid Market Size by Region
8.3.1 Asia Pacific Antacid Sales by Region (2018-2027)
8.3.2 Asia Pacific Antacid Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antacid Market Size by Type
9.1.1 Latin America Antacid Sales by Type (2019-2027)
9.1.2 Latin America Antacid Revenue by Type (2019-2027)
9.2 Latin America Antacid Market Size by Application
9.2.1 Latin America Antacid Sales by Application (2019-2027)
9.2.2 Latin America Antacid Revenue by Application (2019-2027)
9.3 Latin America Antacid Market Size by Country
9.3.1 Latin America Antacid Sales by Country (2019-2027)
9.3.2 Latin America Antacid Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Antacid Market Size by Type
6.1.1 Middle East and Africa Antacid Sales by Type (2016-2027)
6.1.2 Middle East and Africa Antacid Revenue by Type (2016-2027)
6.2 Middle East and Africa Antacid Market Size by Application
6.2.1 Middle East and Africa Antacid Sales by Application (2016-2027)
6.2.2 Middle East and Africa Antacid Revenue by Application (2016-2027)
6.3 Middle East and Africa Antacid Market Size by Country
6.3.1 Middle East and Africa Antacid Sales by Country (2016-2027)
6.3.2 Middle East and Africa Antacid Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AstraZeneca Antacid Product Description
11.1.5 AstraZeneca Related Developments
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Corporation Information
11.2.2 Takeda Pharmaceutical Overview
11.2.3 Takeda Pharmaceutical Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Takeda Pharmaceutical Antacid Product Description
11.2.5 Takeda Pharmaceutical Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Pfizer Antacid Product Description
11.3.5 Pfizer Related Developments
11.4 Reckitt Benckiser
11.4.1 Reckitt Benckiser Corporation Information
11.4.2 Reckitt Benckiser Overview
11.4.3 Reckitt Benckiser Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Reckitt Benckiser Antacid Product Description
11.4.5 Reckitt Benckiser Related Developments
11.5 Bayer
11.5.1 Bayer Corporation Information
11.5.2 Bayer Overview
11.5.3 Bayer Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Bayer Antacid Product Description
11.5.5 Bayer Related Developments
11.6 Procter?Gamble
11.6.1 Procter?Gamble Corporation Information
11.6.2 Procter?Gamble Overview
11.6.3 Procter?Gamble Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Procter?Gamble Antacid Product Description
11.6.5 Procter?Gamble Related Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Corporation Information
11.7.2 GlaxoSmithKline Overview
11.7.3 GlaxoSmithKline Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 GlaxoSmithKline Antacid Product Description
11.7.5 GlaxoSmithKline Related Developments
11.8 Johnson?Johnson
11.8.1 Johnson?Johnson Corporation Information
11.8.2 Johnson?Johnson Overview
11.8.3 Johnson?Johnson Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Johnson?Johnson Antacid Product Description
11.8.5 Johnson?Johnson Related Developments
11.9 CONBA
11.9.1 CONBA Corporation Information
11.9.2 CONBA Overview
11.9.3 CONBA Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 CONBA Antacid Product Description
11.9.5 CONBA Related Developments
11.10 Xiuzheng Pharma
11.10.1 Xiuzheng Pharma Corporation Information
11.10.2 Xiuzheng Pharma Overview
11.10.3 Xiuzheng Pharma Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Xiuzheng Pharma Antacid Product Description
11.10.5 Xiuzheng Pharma Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AstraZeneca Antacid Product Description
11.1.5 AstraZeneca Related Developments
11.12 Bausch Health
11.12.1 Bausch Health Corporation Information
11.12.2 Bausch Health Overview
11.12.3 Bausch Health Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Bausch Health Product Description
11.12.5 Bausch Health Related Developments
11.13 CR SANJIU
11.13.1 CR SANJIU Corporation Information
11.13.2 CR SANJIU Overview
11.13.3 CR SANJIU Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 CR SANJIU Product Description
11.13.5 CR SANJIU Related Developments
11.14 Reddy's Laboratories
11.14.1 Reddy's Laboratories Corporation Information
11.14.2 Reddy's Laboratories Overview
11.14.3 Reddy's Laboratories Antacid Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Reddy's Laboratories Product Description
11.14.5 Reddy's Laboratories Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Antacid Value Chain Analysis
12.2 Antacid Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antacid Production Mode & Process
12.4 Antacid Sales and Marketing
12.4.1 Antacid Sales Channels
12.4.2 Antacid Distributors
12.5 Antacid Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antacid Industry Trends
13.2 Antacid Market Drivers
13.3 Antacid Market Challenges
13.4 Antacid Market Restraints
14 Key Findings in The Global Antacid Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antacid Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Proton Pump Inhibitor
Table 3. Major Manufacturers of H2 Antagonist
Table 4. Major Manufacturers of Acid Neutralizers
Table 5. Global Antacid Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Antacid Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Antacid Sales by Region (2016-2021) & (M Units)
Table 8. Global Antacid Sales Market Share by Region (2016-2021)
Table 9. Global Antacid Sales by Region (2016-2021) & (M Units)
Table 10. Global Antacid Sales Market Share by Region (2022-2027)
Table 11. Global Antacid Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Antacid Revenue Market Share by Region (2016-2021)
Table 13. Global Antacid Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Antacid Revenue Market Share by Region (2022-2027)
Table 15. Global Antacid Sales by Manufacturers (2016-2021) & (M Units)
Table 16. Global Antacid Sales Share by Manufacturers (2016-2021)
Table 17. Global Antacid Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Antacid Revenue Share by Manufacturers (2016-2021)
Table 19. Antacid Price by Manufacturers 2016-2021 (USD/Unit)
Table 20. Global Antacid Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Antacid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antacid as of 2020)
Table 22. Antacid Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Antacid Product Offered
Table 24. Date of Manufacturers Enter into Antacid Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antacid Sales by Type (2016-2021) & (M Units)
Table 27. Global Antacid Sales by Type (2022-2027) & (M Units)
Table 28. Global Antacid Sales Share by Type (2016-2021)
Table 29. Global Antacid Sales Share by Type (2022-2027)
Table 30. Global Antacid Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Antacid Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Antacid Revenue Share by Type (2016-2021)
Table 33. Global Antacid Revenue Share by Type (2022-2027)
Table 34. Antacid Price by Type (2016-2021) & (USD/Unit)
Table 35. Global Antacid Price Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Antacid Sales by Application (2016-2021) & (M Units)
Table 37. Global Antacid Sales by Application (2022-2027) & (M Units)
Table 38. Global Antacid Sales Share by Application (2016-2021)
Table 39. Global Antacid Sales Share by Application (2022-2027)
Table 40. Global Antacid Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Antacid Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Antacid Revenue Share by Application (2016-2021)
Table 43. Global Antacid Revenue Share by Application (2022-2027)
Table 44. Antacid Price by Application (2016-2021) & (USD/Unit)
Table 45. Global Antacid Price Forecast by Application (2022-2027) & (USD/Unit)
Table 46. North America Antacid Sales by Type (2016-2021) & (M Units)
Table 47. North America Antacid Sales by Type (2022-2027) & (M Units)
Table 48. North America Antacid Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Antacid Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Antacid Sales by Application (2016-2021) & (M Units)
Table 51. North America Antacid Sales by Application (2022-2027) & (M Units)
Table 52. North America Antacid Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Antacid Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Antacid Sales by Country (2016-2021) & (M Units)
Table 55. North America Antacid Sales by Country (2022-2027) & (M Units)
Table 56. North America Antacid Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Antacid Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Antacid Sales by Type (2016-2021) & (M Units)
Table 59. Europe Antacid Sales by Type (2022-2027) & (M Units)
Table 60. Europe Antacid Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Antacid Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Antacid Sales by Application (2016-2021) & (M Units)
Table 63. Europe Antacid Sales by Application (2022-2027) & (M Units)
Table 64. Europe Antacid Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Antacid Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Antacid Sales by Country (2016-2021) & (M Units)
Table 67. Europe Antacid Sales by Country (2022-2027) & (M Units)
Table 68. Europe Antacid Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Antacid Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Antacid Sales by Type (2016-2021) & (M Units)
Table 71. Asia Pacific Antacid Sales by Type (2022-2027) & (M Units)
Table 72. Asia Pacific Antacid Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Antacid Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Antacid Sales by Application (2016-2021) & (M Units)
Table 75. Asia Pacific Antacid Sales by Application (2022-2027) & (M Units)
Table 76. Asia Pacific Antacid Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Antacid Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Antacid Sales by Region (2016-2021) & (M Units)
Table 79. Asia Pacific Antacid Sales by Region (2022-2027) & (M Units)
Table 80. Asia Pacific Antacid Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Antacid Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Antacid Sales by Type (2016-2021) & (M Units)
Table 83. Latin America Antacid Sales by Type (2022-2027) & (M Units)
Table 84. Latin America Antacid Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Antacid Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Antacid Sales by Application (2016-2021) & (M Units)
Table 87. Latin America Antacid Sales by Application (2022-2027) & (M Units)
Table 88. Latin America Antacid Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Antacid Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Antacid Sales by Country (2016-2021) & (M Units)
Table 91. Latin America Antacid Sales by Country (2022-2027) & (M Units)
Table 92. Latin America Antacid Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Antacid Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Antacid Sales by Type (2016-2021) & (M Units)
Table 95. Middle East and Africa Antacid Sales by Type (2022-2027) & (M Units)
Table 96. Middle East and Africa Antacid Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Antacid Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Antacid Sales by Application (2016-2021) & (M Units)
Table 99. Middle East and Africa Antacid Sales by Application (2022-2027) & (M Units)
Table 100. Middle East and Africa Antacid Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Antacid Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Antacid Sales by Country (2016-2021) & (M Units)
Table 103. Middle East and Africa Antacid Sales by Country (2022-2027) & (M Units)
Table 104. Middle East and Africa Antacid Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Antacid Revenue by Country (2022-2027) & (US$ Million)
Table 106. AstraZeneca Corporation Information
Table 107. AstraZeneca Description and Major Businesses
Table 108. AstraZeneca Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 109. AstraZeneca Antacid Product
Table 110. AstraZeneca Recent Developments
Table 111. Takeda Pharmaceutical Corporation Information
Table 112. Takeda Pharmaceutical Description and Major Businesses
Table 113. Takeda Pharmaceutical Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 114. Takeda Pharmaceutical Antacid Product
Table 115. Takeda Pharmaceutical Recent Developments
Table 116. Pfizer Corporation Information
Table 117. Pfizer Description and Major Businesses
Table 118. Pfizer Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 119. Pfizer Antacid Product
Table 120. Pfizer Recent Developments
Table 121. Reckitt Benckiser Corporation Information
Table 122. Reckitt Benckiser Description and Major Businesses
Table 123. Reckitt Benckiser Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 124. Reckitt Benckiser Antacid Product
Table 125. Reckitt Benckiser Recent Developments
Table 126. Bayer Corporation Information
Table 127. Bayer Description and Major Businesses
Table 128. Bayer Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 129. Bayer Antacid Product
Table 130. Bayer Recent Developments
Table 131. Procter?Gamble Corporation Information
Table 132. Procter?Gamble Description and Major Businesses
Table 133. Procter?Gamble Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 134. Procter?Gamble Antacid Product
Table 135. Procter?Gamble Recent Developments
Table 136. GlaxoSmithKline Corporation Information
Table 137. GlaxoSmithKline Description and Major Businesses
Table 138. GlaxoSmithKline Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 139. GlaxoSmithKline Antacid Product
Table 140. GlaxoSmithKline Recent Developments
Table 141. Johnson?Johnson Corporation Information
Table 142. Johnson?Johnson Description and Major Businesses
Table 143. Johnson?Johnson Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 144. Johnson?Johnson Antacid Product
Table 145. Johnson?Johnson Recent Developments
Table 146. CONBA Corporation Information
Table 147. CONBA Description and Major Businesses
Table 148. CONBA Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 149. CONBA Antacid Product
Table 150. CONBA Recent Developments
Table 151. Xiuzheng Pharma Corporation Information
Table 152. Xiuzheng Pharma Description and Major Businesses
Table 153. Xiuzheng Pharma Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 154. Xiuzheng Pharma Antacid Product
Table 155. Xiuzheng Pharma Recent Developments
Table 156. Sanofi Corporation Information
Table 157. Sanofi Description and Major Businesses
Table 158. Sanofi Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 159. Sanofi Antacid Product
Table 160. Sanofi Recent Developments
Table 161. Bausch Health Corporation Information
Table 162. Bausch Health Description and Major Businesses
Table 163. Bausch Health Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 164. Bausch Health Antacid Product
Table 165. Bausch Health Recent Developments
Table 166. CR SANJIU Corporation Information
Table 167. CR SANJIU Description and Major Businesses
Table 168. CR SANJIU Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 169. CR SANJIU Antacid Product
Table 170. CR SANJIU Recent Developments
Table 171. Reddy's Laboratories Corporation Information
Table 172. Reddy's Laboratories Description and Major Businesses
Table 173. Reddy's Laboratories Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 174. Reddy's Laboratories Antacid Product
Table 175. Reddy's Laboratories Recent Developments
Table 176. Key Raw Materials Lists
Table 177. Raw Materials Key Suppliers Lists
Table 178. Antacid Distributors List
Table 179. Antacid Customers List
Table 180. Antacid Market Trends
Table 181. Antacid Market Drivers
Table 182. Antacid Market Challenges
Table 183. Antacid Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Antacid Product Picture
Figure 2. Global Antacid Market Share by Type in 2020 & 2027
Figure 3. Proton Pump Inhibitor Product Picture
Figure 4. H2 Antagonist Product Picture
Figure 5. Acid Neutralizers Product Picture
Figure 6. Global Antacid Sales Market Share by Application in 2020 & 2027
Figure 7. OTC Drug
Figure 8. Rx Drug
Figure 9. Antacid Report Years Considered
Figure 10. Global Antacid Sales 2016-2027 (M Units)
Figure 11. Global Antacid Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Antacid Revenue 2016-2027 (US$ Million)
Figure 13. Global Antacid Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Antacid Sales Market Share by Region (2016-2021)
Figure 15. Global Antacid Sales Market Share by Region (2022-2027)
Figure 16. North America Antacid Sales YoY (2016-2027) & (M Units)
Figure 17. North America Antacid Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Antacid Sales YoY (2016-2027) & (M Units)
Figure 19. Europe Antacid Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Antacid Sales YoY (2016-2027) & (M Units)
Figure 21. Asia-Pacific Antacid Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Antacid Sales YoY (2016-2027) & (M Units)
Figure 23. Latin America Antacid Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Antacid Sales YoY (2016-2027) & (M Units)
Figure 25. Middle East & Africa Antacid Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Antacid Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Antacid Revenue in 2020
Figure 28. Antacid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Antacid Sales Market Share by Type (2016-2027)
Figure 30. Global Antacid Revenue Market Share by Type (2016-2027)
Figure 31. Global Antacid Sales Market Share by Application (2016-2027)
Figure 32. Global Antacid Revenue Market Share by Application (2016-2027)
Figure 33. North America Antacid Sales Market Share by Type (2016-2027)
Figure 34. North America Antacid Revenue Market Share by Type (2016-2027)
Figure 35. North America Antacid Sales Market Share by Application (2016-2027)
Figure 36. North America Antacid Revenue Market Share by Application (2016-2027)
Figure 37. North America Antacid Sales Share by Country (2016-2027)
Figure 38. North America Antacid Revenue Share by Country (2016-2027)
Figure 39. U.S. Antacid Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Antacid Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Antacid Sales Market Share by Type (2016-2027)
Figure 42. Europe Antacid Revenue Market Share by Type (2016-2027)
Figure 43. Europe Antacid Sales Market Share by Application (2016-2027)
Figure 44. Europe Antacid Revenue Market Share by Application (2016-2027)
Figure 45. Europe Antacid Sales Share by Country (2016-2027)
Figure 46. Europe Antacid Revenue Share by Country (2016-2027)
Figure 47. Germany Antacid Revenue (2016-2027) & (US$ Million)
Figure 48. France Antacid Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Antacid Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Antacid Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Antacid Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Antacid Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Antacid Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Antacid Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Antacid Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Antacid Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Antacid Revenue Share by Region (2016-2027)
Figure 58. China Antacid Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Antacid Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Antacid Revenue (2016-2027) & (US$ Million)
Figure 61. India Antacid Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Antacid Revenue (2016-2027) & (US$ Million)
Figure 63. Taiwan Antacid Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Antacid Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Antacid Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Antacid Revenue (2016-2027) & (US$ Million)
Figure 67. Philippines Antacid Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Antacid Sales Market Share by Type (2016-2027)
Figure 69. Latin America Antacid Revenue Market Share by Type (2016-2027)
Figure 70. Latin America Antacid Sales Market Share by Application (2016-2027)
Figure 71. Latin America Antacid Revenue Market Share by Application (2016-2027)
Figure 72. Latin America Antacid Sales Share by Country (2016-2027)
Figure 73. Latin America Antacid Revenue Share by Country (2016-2027)
Figure 74. Mexico Antacid Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Antacid Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Antacid Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Antacid Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Antacid Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Antacid Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Antacid Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Antacid Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Antacid Revenue Share by Country (2016-2027)
Figure 83. Turkey Antacid Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Antacid Revenue (2016-2027) & (US$ Million)
Figure 85. U.A.E Antacid Revenue (2016-2027) & (US$ Million)
Figure 86. Antacid Value Chain
Figure 87. Antacid Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
  • Global Colistin Sulphate Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 27-Jul-2021        Price: US 5900 Onwards        Pages: 115
    Colistin, also known as polymyxin E, is an antibiotic produced by certain strains of the bacteria Paenibacillus polymyxa. Colistin is a mixture of the cyclic polypeptides colistin A and B and belongs to the class of polypeptide antibiotics known as polymyxins. Colistin is effective against most Gram-negative bacilli. Colistin is composed of Polymyxins E1 and E2 (or Colistins A, B, and C). Colistin is the least toxic member of the group. Colistin is used as a sulfate or as sulfomethy......
  • 2021-2027 Global and Regional Budesonide Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 27-Jul-2021        Price: US 3500 Onwards        Pages: 131
    The global Budesonide market was valued at 7254.49 Million USD in 2020 and will grow with a CAGR of 3.26% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, Sout......
  • Global Alpha-2 Antiplasmin Sales Market Report 2021
    Published: 26-Jul-2021        Price: US 4000 Onwards        Pages: 145
    The global Alpha-2 Antiplasmin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alpha-2 Antiplasmin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - by Forms - - Plasminogen Binding......
  • Global DNA Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 26-Jul-2021        Price: US 5900 Onwards        Pages: 115
    The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines. Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounti......
  • Global Solid Organ Transplant Immunosuppressant Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 23-Jul-2021        Price: US 5900 Onwards        Pages: 139
    Solid Organ Transplant Immunosuppressant is a class of drugs that suppress or reduce the strength of the body's immune system in solid organ transplant. In China, Solid Organ Transplant Immunosuppressant key players include Roche, Huadong Pharmaceutical, Astellas Pharma, North China Pharmaceutical Huasheng, Hisun, etc. The top five manufacturers hold a share about 65%. Sichuan is the largest market, with a share over 5%, followed by Hebei and Jiangsu, both have a share over 10%. ......
  • Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 23-Jul-2021        Price: US 5900 Onwards        Pages: 113
    Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin Global Varice......
  • Global Podophyllin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 23-Jul-2021        Price: US 5900 Onwards        Pages: 114
    Podophyllin is a non-alkaloid toxin lignan extracted from the roots and rhizomes of Podophyllum species. Under the trade names Condylox, a gel, and Wartec, a solution or cream, it is used on the skin as a topical treatment of external genital warts, caused by some types of the human papillomavirus (HPV), and other warts. PPT and its synthetic derivatives display a wide selection in medical applications such as purgative, vesicant, antirheumatic, antiviral, and antitumor agents. These derivatives......
  • Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 23-Jul-2021        Price: US 5900 Onwards        Pages: 117
    Octreotide is an octapeptide that mimics natural somatostatin pharmacologically?it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid. Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%. Europe is the largest market, with a share over 65%, followed by India and China, b......
  • Global Flomoxef Sodium Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 23-Jul-2021        Price: US 5900 Onwards        Pages: 102
    Flomoxef sodium is an oxacephem antibiotic usually grouped with the cephalosporins. In oxacephems, the sulfur atom of the cephalosporin core is replaced with an oxygen atom. Global Flomoxef Sodium key players include Shionogi & Co., Ltd, Yungjin Pharm. Co., Ltd. Global top two manufacturers hold a share over 95%. Japan is the largest market, with a share over 90%. Market Analysis and Insights: Global Flomoxef Sodium Market In 2020, the global Flomoxef Sodium m......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs